Indico Capital Partners
Indico Capital Partners is an independent venture capital firm based in Lisbon, Portugal, established in 2017. It specializes in investing in global technology companies across various sectors, including software as a service, artificial intelligence, cybersecurity, fintech, and digital platforms. Indico targets investments primarily at the Seed to Series A stages, aiming to support innovative startups that have the potential to become significant players in the market. The firm is led by experienced professionals who have contributed to many of Portugal's successful tech ventures, bringing a wealth of entrepreneurial and investment expertise. Indico seeks to capitalize on the growing entrepreneurship culture in Portugal, bolstered by a strong pool of tech graduates and an emerging startup ecosystem in cities like Lisbon. The firm is committed to identifying and backing the next generation of successful companies that embody the potential of the Portuguese tech landscape.
Arborea
Venture Round in 2024
Arborea Ltd. is a biochemical technology company based in London, United Kingdom, which focuses on developing bio-based products aimed at enhancing urban living and improving wastewater treatment. Founded in 2015 by CEO Julian Melchiorri, Arborea has pioneered the BioSolar Leaf system, an innovative tiling technology that mimics the natural processes of photosynthesis. This system not only sequesters carbon dioxide and generates breathable oxygen but also reduces energy consumption for climate control in buildings and purifies the air. By cultivating microscopic plants, Arborea aims to create a sustainable source of healthy food ingredients and proteins, offering a scalable solution that minimizes production costs while addressing the growing demand for nutritious and environmentally friendly food options.
Membrion, Inc., founded in 2016 and based in Seattle, Washington, specializes in the manufacturing and commercialization of advanced membranes that filter molecules, including ions, under a variety of conditions such as heat, acidity, and biological sensitivity. Originating as a spin-out from the University of Washington, Membrion has received funding from multiple organizations, including the National Science Foundation and private investors, which has facilitated the transition from research to commercial production. The company's innovative ion exchange membrane technology is designed for applications in flow batteries, water purification, fuel cells, and pharmaceuticals, offering clients membranes that feature a longer lifespan and reduced costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.